{
    "eid": "2-s2.0-85082792464",
    "title": "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): Rationale and design of the ESMMO trial",
    "cover-date": "2020-03-30",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Cancer",
        "Clinical trial",
        "Mycophenolate mofetil",
        "Osteosarcoma",
        "Phase II"
    ],
    "authors": [
        "Nut Koonrungsesomboon",
        "Nuttapong Ngamphaiboon",
        "Natavudh Townamchai",
        "Pimpisa Teeyakasem",
        "Chaiyut Charoentum",
        "Pimlak Charoenkwan",
        "Rungrote Natesirinilkul",
        "Lalita Sathitsamitphong",
        "Touch Ativitavas",
        "Parunya Chaiyawat",
        "Jeerawan Klangjorhor",
        "Suradej Hongeng",
        "Dumnoensun Pruksakorn"
    ],
    "citedby-count": 12,
    "ref-count": 58,
    "ref-list": [
        "Review of osteosarcoma and current management",
        "International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons",
        "Age-standardized incidence rates and survival of osteosarcoma in northern Thailand",
        "Epidemiologic study of 112 osteosarcomas in Chiang Mai University Hospital, Thailand",
        "Recent advances in the chemotherapy of metastatic osteogenic sarcoma",
        "The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity",
        "Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols",
        "Osteosarcoma: A meta-analysis and review of the literature",
        "Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?",
        "Sequelae of osteosarcoma medical therapy: A review of rare acute toxicities and late effects",
        "Osteosarcoma overview",
        "Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation",
        "Mycophenolate mofetil in solid-organ transplantation",
        "Mycophenolate mofetil and its mechanisms of action",
        "Mycophenolate mofetil: An update",
        "Anti-tumor potential of IMP dehydrogenase inhibitors: A century-long story",
        "Overexpression of inosine 5\u2032-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells",
        "Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumour growth and metastasis in osteosarcoma treatment",
        "Exploring targeted therapy of osteosarcoma using proteomics data",
        "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)",
        "RECIST 1.1 - Update and clarification: From the RECIST committee",
        "Validation of the Thai version of brief pain inventory (BPI-T) in cancer patients",
        "Tiazofurin: Molecular and clinical action",
        "Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout",
        "Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients",
        "Update on the teratogenicity of maternal mycophenolate mofetil",
        "The safety of mycophenolate mofetil in pregnancy",
        "Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis",
        "Infection in organ transplantation",
        "Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation",
        "Mycophenolic acid and its pharmacokinetic drug-drug interactions in humans: Review of the evidence and clinical implications",
        "Stopping rules for phase II studies",
        "Planned versus attained design in phase II clinical trials",
        "P-value calculation for multistage phase II cancer clinical trials",
        "Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials",
        "Confidence intervals for a binomial parameter following a multistage test with application to MIL-STD 105D and medical trials",
        "A meta-analysis of osteosarcoma outcomes in the modern medical era",
        "Clinical trial designs for rare diseases: Studies developed and discussed by the international rare cancers initiative",
        "Phase-II trials in osteosarcoma recurrences: A systematic review of past experience",
        "The design of phase II clinical trials testing cancer therapeutics: Consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee",
        "Progress in the chemotherapeutic treatment of osteosarcoma",
        "Response evaluation criteria in solid tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma",
        "Evaluation of response after neoadjuvant treatment in soft tissue sarcoma; the European Organization for Research and Treatment of Cancer - Soft tissue and bone sarcoma group (EORTC-STBSG) recommendations for pathological examination and reporting",
        "Outcome of patients with recurrent osteosarcoma enrolled in seven phase II trials through Children's Cancer group, pediatric oncology group, and Children's oncology group: Learning from the past to move forward",
        "Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience",
        "Pediatric phase i trials in oncology: An analysis of study conduct efficiency",
        "Long-term safety of mycophenolate mofetil and cyclosporine: A review",
        "Mycophenolate mofetil in organ transplantation: Focus on metabolism, safety and tolerability",
        "Limits to intensified mycophenolate mofetil dosing in kidney transplantation",
        "Phase i clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients",
        "Crohn's-like changes in the colon due to mycophenolate?",
        "The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours",
        "Comparison of error rates in single-arm versus randomized phase II cancer clinical trials",
        "Effect of a misspecification of response rates on type i and type II errors, in a phase II Simon design",
        "Optimal two-stage designs for phase II clinical trials",
        "Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival",
        "Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the cooperative osteosarcoma study group (COSS)",
        "EORTC soft tissue and bone sarcoma group. Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}